Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: A pathognomonic feature of potentially lethal disease?

39Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Cutaneous manifestations in disseminated strongyloidiasis are infrequent but should raise the suspicion for its diagnosis. We retrospectively evaluated the charts of six patients with cancer and a proven diagnosis of disseminated strongyloidiasis. All patients had received prophylaxis with albendazole before starting antineoplastic therapy, which included high-dose steroids. They presented with septic shock, acute respiratory failure and characteristic purpuric periumbilical skin lesions. Strongyloides larvae were identified in tracheal aspirates (n=5), gastric aspirates (n=4), lung (n=2) and skin biopsies (n=2). All patients died despite antihelminthic therapy and intensive care support. © 2005 by The Brazilian Journal of Infectious Diseases and Contexto Publishing. All rights reserved.

Cite

CITATION STYLE

APA

Salluh, J. I. F., Bozza, F. A., Pinto, T. S., Toscano, L., Weller, P. F., & Soares, M. (2005). Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: A pathognomonic feature of potentially lethal disease? Brazilian Journal of Infectious Diseases, 9(5), 419–424. https://doi.org/10.1590/S1413-86702005000500010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free